Pharmaceuticals for treating prostatic cancer; pharmaceuticals for treating endometriosis; pharmaceuticals for treating premenopausal breast cancer; pharmaceuticals for treating uterine leiomyomata; pharmaceuticals for treating central precocious puberty; pharmaceuticals for treating cancer; pharmaceuticals for gynecological purposes; pharmaceutical preparations, namely a hormone modifying agent; leuprorelin acetate for pharmaceutical purposes